"Das Klinikum Bremen-Mitte bietet seinen Patientinnen und Patienten eine kompetente und leistungsstarke medizinische, pflegerische und psychosoziale Versorgung und ist ein Krankenhaus der Maximalversorgung. Wir verfügen über alle notwendigen personellen und apparativen Voraussetzungen, um auch Schwerstkranke und -verletzte zu behandeln. Wir möchten, dass Sie sich gut aufgehoben fühlen und möglichst schnell wieder gesund werden. Unsere Mitarbeiterinnen und Mitarbeiter sorgen dafür, dass Sie medizinisch optimal versorgt und gepflegt werden."

During the past decade, Klinikum Bremen-Mitte conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Bremen-Mitte" #1 sponsor was "University of Ulm" with 8 trials, followed by "AGO Study Group" with 4 trials sponsored, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 4 trials sponsored, "Universitätsklinikum Hamburg-Eppendorf" with 4 trials sponsored and "University of Jena" with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bremen-Mitte" #1 collaborator was "ClinAssess GmbH" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator, "Hannover Medical School" with 2 trials as a collaborator and "Hoffmann-La Roche" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Bremen-Mitte" are "Ovarian Cancer" (7 trials), "Leukemia" (6 trials), "Acute Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (5 trials) and "Fallopian Tube Cancer" (5 trials). Many other conditions were trialed in "Klinikum Bremen-Mitte" in a lesser frequency.

Most popular intervention types in "Klinikum Bremen-Mitte" are "Drug" (54 trials), "Biological" (14 trials), "Radiation" (13 trials), "Procedure" (10 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "carboplatin" (9 trials), "radiation therapy" (9 trials), "Cytarabine" (7 trials), "cyclophosphamide" (7 trials) and "doxorubicin hydrochloride" (7 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Bremen-Mitte" are 57 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Bremen-Mitte". undefined are not yet recruiting, 12 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Klinikum Bremen-Mitte, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Bremen-Mitte, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".